Literature DB >> 23837579

Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration.

Quanlei Zhu1, Tao Guo, Dengning Xia, Xiuying Li, Chunliu Zhu, Haiyan Li, Defang Ouyang, Jiwen Zhang, Yong Gan.   

Abstract

OBJECTIVE: The aim of this study was to investigate Pluronic F127-modified liposome-containing cyclodextrin (CD) inclusion complex (FLIC) for improving the solubility, cellular uptake and intestinal penetration of tacrolimus (FK 506) in the gastrointestinal (GI) tract.
METHODS: Molecular modelling was performed to screen the optimal CD for the solubilization of FK 506. FLIC was prepared by thin-lipid film hydration with the inclusion complex solutions followed by membrane extrusion. Dilution tests were conducted in simulated gastric fluids and phosphate-buffered solution of sodium taurocholate to investigate the solubility improvement of FK506. The cellular uptake of nanocarriers was studied in Caco-2 cells, and intestinal mucous membrane penetration in the GI tract was evaluated in Sprague-Dawley rats. KEY
FINDINGS: The results showed that β-CD had the strongest binding energy with the guest molecule among the CDs. The prepared FLIC has an average diameter of 180.8 ± 8.1 nm with a spherical shape. The solubility and cellular uptake of FK 506 was greatly improved by the incorporation of CD complexes in the Pluronic F127-modified liposomes. Intestinal mucous membrane penetration was also significantly improved by the preparation of FLIC.
CONCLUSION: With improved drug solubility and intestinal mucous membrane penetration, FLIC shows a promising oral delivery system for FK 506.
© 2013 Royal Pharmaceutical Society.

Entities:  

Keywords:  Pluronic F127-modified liposomes; cellular uptake; cyclodextrin inclusion complex; molecular modelling; solubility; tacrolimus

Mesh:

Substances:

Year:  2013        PMID: 23837579     DOI: 10.1111/jphp.12074

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Remote loading of preencapsulated drugs into stealth liposomes.

Authors:  Surojit Sur; Anja C Fries; Kenneth W Kinzler; Shibin Zhou; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-28       Impact factor: 11.205

2.  Preliminary In Vivo Safety Evaluation of a Tacrolimus Eye Drop Formulation Using Hydroxypropyl Beta Cyclodextrin After Ocular Administration in NZW Rabbits.

Authors:  Asma Mahmoudi; Bizhan Malaekeh-Nikouei; Mohammad Yahya Hanafi-Bojd; Mojtaba Toloei; Mehran Hosseini; Malihe Nikandish
Journal:  Clin Ophthalmol       Date:  2020-03-27

3.  Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy.

Authors:  Lan Li; Jingyu Ni; Min Li; Jingrui Chen; Lifeng Han; Yan Zhu; Deling Kong; Jingyuan Mao; Yi Wang; Boli Zhang; Meifeng Zhu; Xiumei Gao; Guanwei Fan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Improvement of Butamben Anesthetic Efficacy by the Development of Deformable Liposomes Bearing the Drug as Cyclodextrin Complex.

Authors:  Paola Mura; Francesca Maestrelli; Marzia Cirri; Giulia Nerli; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Natascia Mennini
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

5.  Transcytosis of Bacillus subtilis extracellular vesicles through an in vitro intestinal epithelial cell model.

Authors:  Ana Paula Domínguez Rubio; Jimena Martínez; Marcos Palavecino; Federico Fuentes; Christian Miquel Sánchez López; Antonio Marcilla; Oscar Edgardo Pérez; Mariana Piuri
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

6.  Predicting complexation performance between cyclodextrins and guest molecules by integrated machine learning and molecular modeling techniques.

Authors:  Qianqian Zhao; Zhuyifan Ye; Yan Su; Defang Ouyang
Journal:  Acta Pharm Sin B       Date:  2019-05-08       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.